findmyKOL

John Rozanski, MD

Basic profile

Broward Health Medical Center

ORCIDNone on fileNPI↗
✓ Full record
RegionFort Lauderdale, FL · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2024findmyKOL type: RegionalLatest publication2008Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

John Rozanski is a Cardiology physician affiliated with Broward Health Medical Center. OpenAlex indexes 83 publications with 1,295 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
83publications

Distinct works indexed by OpenAlex.

1,295citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1625 SE 3rd Ave Ste 300
Fort Lauderdale, FL 333162521

Telephone

954-355-4665

Provider last certified this registry record 3 Apr 2024.

View the NPPES registry record

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87%
    Beta blocker20.4%
    Metoprolol Succinate53%Carvedilol22%Atenolol14%Metoprolol Tartrate5%Sotalol2%Nebivolol Hcl2%Bisoprolol Fumarate2%
    Part D<11 patients
    Statin18.2%
    Atorvastatin Calcium61%Rosuvastatin Calcium31%Simvastatin5%Lovastatin3%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    9.5%
    Factor Xa inhibitor6.9%
    Eliquis73%Xarelto28%
    Part D≥52 patients
    P2Y12 inhibitor2.5%
    Clopidogrel100%
    Part D≥27 patients
  • Metabolism & gastrointestinal

    2.7%
    SGLT2 inhibitor2.3%
    Farxiga100%
    Part D≥28 patients
    Potassium supplement0.4%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)36% facility · 64% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”